Date: July 31, 2019; Source: Fred Hutchinson Cancer Research Center; Summary: Researchers have used CRISPR-Cas9 to edit long-lived blood stem cells to reverse the clinical symptoms observed with several blood disorders, including sickle cell disease ...
Read More
Read More
Comments
Post a Comment